Sarepta Therapeutics jumps on plan to cut 500 jobs
ReutersJul 16, 2025 8:19 PM
Shares of drug developer Sarepta Therapeutics SRPT.O surge 50% to $27.60 in extended trading
Co says it will cut 36% of its workforce, about 500 jobs, saving around $400 million annually
As of December 31, 2024, co had 1,372 employees - SEC filing
The FDA will add a black box warning to co's gene therapy, Elevidys, for serious liver risks
Co appoints Ryan Wong as chief financial officer
Stock down 85% YTD
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
How Bitcoin Miners Are Scaling Revenue Through AI Data Center Integration
Discover how Bitcoin miners like Core Scientific and IREN are scaling revenue by pivoting to AI data centers. Explore 2026 hashprice trends, ASIC-to-GPU retrofitting, and the "hashrate-to-HPC" revolution.TradingKey
Sun, Feb 22
Stock Market Crash 2026: What Fed Signals and Economic Data Mean for Investors
TradingKey - The possibility of a stock market crash occurring in 2026 is becoming increasingly likely as investor sentiment continues to decline.TradingKey
Thu, Feb 19
New Fed Chair Warsh Takes Office: Major Shift in Monetary Policy? US Dollar Short-Term Rebound, 2026 Investment Strategy Analysis
TradingKey - At the start of 2026, global financial markets witnessed a major leadership change as U.S. President Trump officially nominated Kevin Warsh as the next Federal Reserve Chair. Pending Senate confirmation, he will succeed Jerome Powell this May to lead the world’s most influential central bank.TradingKey
Thu, Feb 19
